Technology
Health
Biotechnology

Rhythm Pharmaceuticals

216

$16.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.64 (+4.14%) As of 1:15 PM EDT today
+$0.64 (+4.14%) Today

Why Robinhood?

You can buy or sell RYTM and other stocks, options, ETFs, and crypto commission-free!

About RYTM

Rhythm Pharmaceuticals, Inc. engages in developing and commercializing peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. It focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity. Read More Its product candidate includes setmelanotide, an MC4R agonist designed to restore impaired MC4R pathway function caused by genetic variants that occur upstream of the MC4R. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

CEO
Hunter C. Smith
Employees
70
Headquarters
Boston, Massachusetts
Founded
2010
Market Cap
634.89M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
327.57K
High Today
$16.24
Low Today
$15.21
Open Price
$15.71
Volume
126.01K
52 Week High
$29.13
52 Week Low
$12.99

Collections

Technology
Health
Biotechnology
Therapy
2017 IPO
US
North America

RYTM Earnings

-$1.24
-$0.83
-$0.41
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 1, Pre-Market

People Also Bought

Viking Therapeutics

52,601

$4.79

+3.01%

Viking Therapeutics

52,601

$4.79

+3.01%

Myovant Sciences

5,193

$8.23

-3.86%

Sangamo Therapeutics

7,470

$7.01

+3.55%

Precision BioSciences

6,325

$5.62

-0.97%

You May Also Like

EXTN
DJCI
ALB
EW
STXB
ENZL
IMH
IHD
TOELY
SKOR
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy RYTM

Market Price$16.11
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell RYTM stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up